-
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
[ad_1] San Diego, CA – (NewMediaWire) – November 22, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly…
Read More » -
News
Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial
Clearmind Medicine Inc. announced the initiation of clinical batches of production of its novel psychedelic-derived drug candidate, the MEAI- based…
Read More » -
Can B Corp. Reports Growth of 51% to $2.9 Million Revenue for Third Quarter 2022, the Highest Quarterly Revenue in Company History
[ad_1] Led by a Significant Increase in Duramed, Music City Botanical and Botanical Biotech Brands Adjusted EBITDA Loss Decreased…
Read More » -
Persistent asthma linked to increased buildup of plaque in arteries leading to the brain
[ad_1] Research Highlights: An analysis of data for more than 5,000 adults has found that those with persistent asthma appeared…
Read More » -
Hemp, Inc. Reports: Marijuana-Cannabidiol (CBD) Bill Signals New Era in Federal Cannabis Policy
[ad_1] Las Vegas, NV – (NewMediaWire) – November 22, 2022 – Hemp, Inc. (OTC PINK: HEMP): It’s a new dawn,…
Read More »